MicroRNA miR-150 Is Involved in Vα14 Invariant NKT Cell Development and Function

被引:64
作者
Zheng, Quanhui
Zhou, Li [2 ]
Mi, Qing-Sheng [1 ,2 ]
机构
[1] Henry Ford Hlth Syst, Henry Ford Immunol Program, Dept Dermatol, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI 48202 USA
关键词
KILLER T-CELLS; RECEPTOR-ALPHA-CHAIN; FACTOR C-MYB; NATURAL-KILLER; IL-4; PRODUCTION; GENE-EXPRESSION; IFN-GAMMA; DIFFERENTIATION; ACTIVATION; LINEAGE;
D O I
10.4049/jimmunol.1103342
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD1d-restricted V alpha 14 invariant NKT (iNKT) cells play an important role in the regulation of diverse immune responses. MicroRNA-mediated RNA interference is emerging as a crucial regulatory mechanism in the control of iNKT cell differentiation and function. Yet, roles of specific microRNAs in the development and function of iNKT cells remain to be further addressed. In this study, we identified the gradually increased expression of microRNA-150 (miR-150) during the maturation of iNKT cells in thymus. Using miR-150 knockout (KO) mice, we found that miR-150 deletion resulted in an interruption of iNKT cell final maturation in both thymus and periphery. Upon activation, iNKT cells from miR-150KO mice showed significantly increased IFN-gamma production compared with wild-type iNKT cells. Bone marrow-transferring experiments demonstrated the cell-intrinsic characteristics of iNKT cell maturation and functional defects in mice lacking miR-150. Furthermore, miR-150 target c-Myb was significantly upregulated in miR-150KO iNKT cells, which potentially contribute to iNKT cell defects in miR-150KO mice. Our data define a specific role of miR-150 in the development and function of iNKT cells. The Journal of Immunology, 2012, 188: 2118-2126.
引用
收藏
页码:2118 / 2126
页数:9
相关论文
共 59 条
  • [11] The Adaptor Molecule Signaling Lymphocytic Activation Molecule-Associated Protein (SAP) Regulates IFN-γ and IL-4 Production in Vα14 Transgenic NKT Cells via Effects on GATA-3 and T-bet Expression
    Cen, Osman
    Ueda, Aki
    Guzman, Laura
    Jain, Jimmy
    Bassiri, Hamid
    Nichols, Kim E.
    Stein, Paul L.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (03) : 1370 - 1378
  • [12] Impaired NK1(+) T cell development and early IL-4 production in CD1-deficient mice
    Chen, YH
    Chiu, NM
    Mandal, M
    Wang, N
    Wang, CR
    [J]. IMMUNITY, 1997, 6 (04) : 459 - 467
  • [13] Ciprés A, 1999, EUR J IMMUNOL, V29, P1158, DOI 10.1002/(SICI)1521-4141(199904)29:04<1158::AID-IMMU1158>3.0.CO
  • [14] 2-L
  • [15] CONSTITUTIVE EXPRESSION OF A C-MYB CDNA BLOCKS FRIEND MURINE ERYTHROLEUKEMIA CELL-DIFFERENTIATION
    CLARKE, MF
    KUKOWSKALATALLO, JF
    WESTIN, E
    SMITH, M
    PROCHOWNIK, EV
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 884 - 892
  • [16] AN INVARIANT V-ALPHA-24-J-ALPHA-Q/V-BETA-11 T-CELL RECEPTOR IS EXPRESSED IN ALL INDIVIDUALS BY CLONALLY EXPANDED CD4-8- T-CELLS
    DELLABONA, P
    PADOVAN, E
    CASORATI, G
    BROCKHAUS, M
    LANZAVECCHIA, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 1171 - 1176
  • [17] A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
    Dhodapkar, MV
    Geller, MD
    Chang, DH
    Shimizu, K
    Fujii, SI
    Dhodapkar, KM
    Krasovsky, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) : 1667 - 1676
  • [18] Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors
    Egawa, T
    Eberl, G
    Taniuchi, I
    Benlagha, K
    Geissmann, F
    Hennighausen, L
    Bendelac, A
    Littman, DR
    [J]. IMMUNITY, 2005, 22 (06) : 705 - 716
  • [19] NIK-dependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells
    Elewaut, D
    Shaikh, RB
    Hammond, KJL
    De Winter, H
    Leishman, AJ
    Sidobre, S
    Turovskaya, O
    Prigozy, TI
    Ma, L
    Banks, TA
    Lo, D
    Ware, CF
    Cheroutre, H
    Kronenberg, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) : 1623 - 1633
  • [20] Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses
    Exley, MA
    Tahir, SMA
    Cheng, O
    Shaulov, A
    Joyce, R
    Avigan, D
    Sackstein, R
    Balk, SP
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (10) : 5531 - 5534